CClinicalTrials.gg
Not yet recruitingNCT07845526Tele-PARTIUpdated Sep 29, 2026

Enhanced Telemedicine in Primary Care for Acute Respiratory Tract Infections Study

An interventional study of Tele-Otoscope Enabled Primary Care and eBook-supported primary care in Acute Respiratory Tract Infection, Ear Infection and Throat Infection, sponsored by University of Pittsburgh. Not yet recruiting at 2 sites in United States. Open to participants aged 6 Months to 24 Months. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
6 Months to 24 Months
Sex
All
01

Study summary

Young children often receive antibiotics for pediatric acute respiratory tract infections (ARTIs) - common childhood diagnoses like ear infections, strep throat, sinusitis, and colds - but many of these antibiotics are prescribed unnecessarily for viral infections, where antibiotics will not help. Helping families and pediatricians to evaluate children with ARTIs through primary care telemedicine visits using at-home tele-otoscopes vs. at-home eBooks could help reduce unnecessary antibiotic exposure in children. In this clinical trial, we will assess the impact of at-home tele-otoscope vs. eBook enabled primary care telemedicine on antibiotic use, healthcare utilization, and healthcare costs for young children.

Read the detailed description

This is an interventional study. In this two-arm randomized controlled trial, randomization will occur stratified by child age at enrollment (6-14 months, 15-23 months) and study site. The trial will be conducted in academic and community pediatric practices. This study includes two prespecified, parallel analyses in the following aims:

Aim 1: Assess the impact of tele-otoscope vs. eBook enabled primary care practice (PCP) telemedicine for pediatric ARTIs on antibiotic prescribing and healthcare utilization among young children who have at least one prior episode of AOM.

Aim 2: Assess the economic consequences from a payer perspective of providing at-home tele-otoscopes vs. eBooks to young children who have at least a prior episode of AOM.

02

Conditions studied

  • Acute Respiratory Tract Infection
  • Ear Infection
  • Throat Infection
  • Acute Respiratory Tract Infections
  • Common Cold

Keywords

  • acute respiratory tract infection
  • ear infection
  • pediatric
  • telemedicine
03

Who can participate

Ages eligible
6 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Child receives primary care at a participating study site
  • Child is between 6 months 0 days and 23 months 29 days
  • Child has one or more documented acute otitis media infections (diagnosed on the day of enrollment or previously)
  • Child presents with an adult who is the biological parent or legally authorized representative able to provide consent for the child's participation in the study.

Exclusion criteria

Exclusion Criteria:

  • Adult caregiver not able to participate in informed consent in English or Spanish
  • Child has congenital anomaly of face or ears
  • Child has history of myringotomy tube placement
  • Family lacks smart phone in household to pair with otoscope
  • Sibling or other child in same household already enrolled
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
450 participants (estimated)

Study arms

  • Experimental
    Tele-Otoscope

    Children randomized to the experimental arm will receive a tele- otoscope and ear irrigation device (to assist cerumen removal if needed); parents will be trained on the use of these devices. Parents will be asked to download the tele-otoscope app which will allow them to view and record from the tele-otoscope camera. These devices (tele-otoscope and ear irrigation device) are commercially available and their functionality is not being tested in this study.

    Other: Tele-Otoscope Enabled Primary Care

  • Placebo comparator
    eBook

    Children randomized to the control arm will receive an eBook on baby and toddler care from the American Academy of Pediatrics. As in prior studies of tele-services, we will provide the eBook as a "digital placebo." Thus, participants in both arms receive an electronic resource, but the eBook has limited content specific to ARTI care, such that it is not expected to significantly influence study outcomes.

    Other: eBook-supported primary care

Interventions

  • OtherTele-Otoscope Enabled Primary Care

    Children randomized to the experimental arm will receive a tele- otoscope and ear irrigation device (to assist cerumen removal if needed); parents will be trained on the use of these devices. Parents will be asked to download the tele-otoscope app which will allow them to view and record from the tele-otoscope camera. These devices (tele-otoscope and ear irrigation device) are commercially available and their functionality is not being tested in this study, which focuses instead on testing the impact of their availability when integrated into primary care telemedicine.

  • OthereBook-supported primary care

    Children randomized to the control arm will receive an eBook on baby and toddler care from the American Academy of Pediatrics. As in prior studies of tele-services, we will provide the eBook as a "digital placebo." Thus, participants in both arms receive an electronic resource, but the eBook has limited content specific to ARTI care, such that it is not expected to significantly influence study outcomes.

05

What researchers measure

Primary outcomes

  1. Number of ARTI antibiotics

    Number of antibiotic courses prescribed for acute respiratory tract infections (ARTIs) per participant from enrollment through 12 months after enrollment. An antibiotic course is defined according to the study protocol. This is the primary outcome for the first pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  2. Total annual healthcare costs from the payer perspective

    Total healthcare costs incurred per participant from the payer perspective from enrollment through 12 months after enrollment, reported in U.S. dollars. This is the primary outcome for the second pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

Secondary outcomes

  1. Number of ARTI antibiotic days prescribed

    Total number of days of antibiotic therapy prescribed for ARTI per participant from enrollment through 12 months after enrollment. This is a secondary outcome for the first pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  2. Number of ARTI broad-spectrum antibiotic courses

    Number of broad-spectrum antibiotic courses prescribed for ARTI per participant from enrollment through 12 months after enrollment. Broad-spectrum antibiotics are defined according to the study protocol. This is a secondary outcome for the first pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  3. Number of total antibiotic courses (any diagnosis)

    Number of antibiotic courses prescribed for any diagnosis per participant from enrollment through 12 months after enrollment. This is a secondary outcome for the first pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  4. Number of ARTI visits overall and by site (ED, urgent care, primary care)

    Number of visits for acute respiratory tract infections (ARTIs) per participant from enrollment through 12 months after enrollment, summarized overall and by visit setting (emergency department, urgent care, and primary care). This is a secondary outcome for the first pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  5. Percentage of ARTI visits resulting in antibiotic prescription

    Percentage of ARTI visits resulting in an antibiotic prescription from enrollment through 12 months after enrollment, summarized overall and by visit setting (emergency department, urgent care, and primary care). This is a secondary outcome for the first pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  6. Total annual family out of pocket costs

    Total family out-of-pocket healthcare costs per participant from enrollment through 12 months after enrollment, reported in U.S. dollars. This is a secondary outcome for the second pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

  7. Total annual costs from the primary care practice perspective

    Total healthcare costs from the primary care practice perspective per participant from enrollment through 12 months after enrollment, reported in U.S. dollars. This is a secondary outcome for the second pre-specified analysis.

    Time frame: From enrollment through 12 months after enrollment

06

Study locations

2 sites
  • UPMC Children's Community Pediatrics
    Pittsburgh, Pennsylvania 15213, United States
  • UPMC Children's Hospital of Pittsburgh Primary Care Center
    Pittsburgh, Pennsylvania 15213, United States
    • Kristin Ray, MD, MS · Contact · knr16@pitt.edu · 412-465-0173‬
    • Kristin Ray, MD, MS · Principal investigator
07

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (test, tables, figures, and appendices).

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07845526
Lead sponsor
University of Pittsburgh
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Responsible party
Kristin Ray (Associate Professor of Pediatrics, University of Pittsburgh) — Principal investigator
First posted
Sep 29, 2026
Start date
Nov 2026 (estimated)
Primary completion
Apr 2030 (estimated)
Completion
Apr 2030 (estimated)
Last update
Sep 29, 2026

Study contacts

Kristin Ray, MD, MS
Contact
knr16@pitt.edu
412-465-0173‬
Kristin Ray, MD, MS
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion